In situ vaccine application of inactivated CPMV nanoparticles for cancer immunotherapy

Cowpea mosaic virus (CPMV) is currently in the development pipeline for multiple biomedical applications, including cancer immunotherapy. In particular the application of CPMV as in situ vaccine has shown promise; here the plant viral nanoparticle is used as an adjuvant and is injected directly into...

Descripción completa

Detalles Bibliográficos
Autores principales: Chariou, Paul L., Beiss, Veronique, Ma, Yifeng, Steinmetz, Nicole F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: RSC 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323807/
https://www.ncbi.nlm.nih.gov/pubmed/34368764
http://dx.doi.org/10.1039/d0ma00752h

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323807/
https://www.ncbi.nlm.nih.gov/pubmed/34368764
http://dx.doi.org/10.1039/d0ma00752h

Ejemplares similares